Display Settings:

Format

Send to:

Choose Destination
Nat Chem Biol. 2012 Jan 22;8(3):232-4. doi: 10.1038/nchembio.767.

Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin.

Author information

  • 1Department of Chemistry, Washington University School of Medicine, St. Louis, Missouri, USA.

Abstract

Neuropathic pain is a debilitating condition for which the development of effective treatments has been limited by an incomplete understanding of its chemical basis. We show by using untargeted metabolomics that sphingomyelin-ceramide metabolism is altered in the dorsal horn of rats with neuropathic pain and that the upregulated, endogenous metabolite N,N-dimethylsphingosine induces mechanical hypersensitivity in vivo. These results demonstrate the utility of metabolomics to implicate unexplored biochemical pathways in disease.

Comment in

PMID:
22267119
[PubMed - indexed for MEDLINE]
PMCID:
PMC3567618
Free PMC Article

Images from this publication.See all images (2)Free text

Fig. 1
Fig. 2
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Write to the Help Desk